1) thrombocytosis
[,θrɔmbəusai'təusis]
血小板增多症
1.
Analysis of hemogram,iron staining in bone marrow and iron metabolism in 98 patients with thrombocytosis;
98例血小板增多症患者血象、骨髓铁染色及铁代谢分析
2.
Secondary thrombocytosis due to imipenem-cilastatin sodium
亚胺培南-西司他丁钠致继发性血小板增多症
2) Thrombocythemia
血小板增多症
1.
Clinical Analysis on 40 Cases of Essential Thrombocythemia;
原发性血小板增多症40例临床分析
3) essential thrombocythemia
原发性血小板增多症
1.
Treatment of combining plateletpheresis,Me-CCNU and α-interferon in 8 cases with essential thrombocythemia;
血小板单采清除术联合甲环亚硝脲、α-干扰素治疗原发性血小板增多症8例
2.
Objective To analyze the mutation allele ratio in polycythemia vera(PV) and essential thrombocythemia(ET) samples.
目的定量检测并分析JAK2V617F突变等位基因在真性红细胞增多症(polycythemia vera,PV)和原发性血小板增多症(essential thrombocythemia,ET)中的分布情况。
3.
This study was aimed to investigate the correlation of thrombosis with increased platelet turnover in essential thrombocythemia.
为了对原发性血小板增多症血小板更新率(turnover)变化与血栓形成的关系进行分析,根据有无血栓症状将26例原发性血小板增多症(ET)患者分成两组,应用流式细胞术检测网织血小板(RP),选择26名健康献血者作为对照。
5) reactive thrombocythemia
反应性血小板增多症
1.
Experimental study on correlation between reactive thrombocythemia and pseudohyperkalemia in children;
儿童反应性血小板增多症与假性高血清钾症的相关性实验研究
6) primary thrombocytosis
原发性血小板增多症
1.
This study was aimed to investigate the incidence of thrombosis in patients with primary thrombocytosis(PT) and its correlation with function changes of platelets,and to explore the effect of thromboxane A2(TXA2) inhibitor-ozagrel sodium on platelet activity and its efficacy for prevention and treatment of thrombosis.
本研究观察了原发性血小板增多症(primary thrombocytosis,PT)患者临床血栓发生率及其与血小板功能变化的关系,探讨PT患者预防性应用血栓素A2抑制剂对其血小板活性的影响及其对血栓的预防和治疗的临床效果。
补充资料：血小板增多症
血小板增多症
thrombocytosis
一般将外周血液中血小板数持续增多达400×109/L以上者称为血小板增多症。按病因分为两类：①骨髓增生性疾病：包括原发性血小板增多症、真性红细胞增多症、慢性粒细胞性白血病等，血小板常伴有形态及功能异常，可发生出血或血栓形成。②继发性血小板增多症：见于炎症性疾病、恶性肿瘤及脾切除术后等，血小板形态及功能正常，如血小板数过高，亦可有血栓形成。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条